Y5Z-78195-79892
4 vaccinations
3 coded responses
26 check-ins
3 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 31-35
- ZIP prefix
- 815 / CO
- Registered
- 2021-03-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-17
Registered in v-safe
-
2021-03-17
Dose 1 — Pfizer-BioNTech
- 2021-03-17
- 2021-03-19
- 2021-03-20
- 2021-03-21
-
2021-03-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-23
- 2021-03-24
- 2021-03-31
-
2021-04-08
Dose 2 — Pfizer-BioNTech
-
2021-04-08
Survey response — day 0, dose 2MedDRA: Disturbance in attention, Feeling abnormal, Nasopharyngitis — Feeling: Good · Site: Pain · Headache, Fatigue or tirednessFree text: Mild foggy brain/trouble concentrating, reminiscent of a coldMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-07-08
-
2021-10-09
Survey response — 6 months, dose 2MedDRA: Gastrointestinal disorder — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Digestive issues, possibly related to a newly developing food allergy, or to gastritis. Does not seem related to COVID-19 in any way.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-09
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-10-13
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2021-11-30
Dose 3 — Pfizer-BioNTech
- 2022-04-13
-
2022-10-07
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-12-02
Survey response — 12 months, dose 3MedDRA: Asthma, COVID-19, Pre-existing disease — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I had COVID (BA.4 or BA.5) in early June, though I recovered (and was grateful to my booster for lessening my symptoms). I have experienced a return of asthma symptoms since Aug, which may be related to having COVID, but certainly not to the vaccine.MedDRA releases: 2024-11 · check-in free text available
- 2023-04-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-17 | Pfizer-BioNTech | |
| 2 | 2021-04-08 | Pfizer-BioNTech | |
| 3 | 2021-11-30 | Pfizer-BioNTech | No |
| 4 | 2022-10-07 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-09 | Successful 2021-10-13 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 7 — day 0, dose 2
Systemic reaction (other): Mild foggy brain/trouble concentrating, reminiscent of a cold
Release 10 — 6 months, dose 2
Symptoms: Digestive issues, possibly related to a newly developing food allergy, or to gastritis. Does not seem related to COVID-19 in any way.
Release 12 — 12 months, dose 3
Symptoms: I had COVID (BA.4 or BA.5) in early June, though I recovered (and was grateful to my booster for lessening my symptoms). I have experienced a return of asthma symptoms since Aug, which may be related to having COVID, but certainly not to the vaccine. cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Disturbance in attention | ✓ | ✓ | ✓ |
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
| SRO | Nasopharyngitis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release